Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 4,720 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 4,720 shares of the firm’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $128,903.20. Following the completion of the sale, the senior vice president now owns 110,309 shares in the company, valued at $3,012,538.79. The trade was a 4.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Wednesday, January 15th, Amy Beth Vanduyn sold 604 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $16,295.92.
• On Monday, January 6th, Amy Beth Vanduyn sold 1,311 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $34,885.71.
• On Tuesday, December 3rd, Amy Beth Vanduyn sold 25,447 shares of Phreesia stock. The shares were sold at an average price of $20.93, for a total transaction of $532,605.71.

Phreesia Stock Performance

Shares of NYSE PHR opened at $27.89 on Friday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.16. The firm has a 50-day moving average price of $24.00 and a 200 day moving average price of $23.00.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter last year, the business earned ($0.58) earnings per share. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. Research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent analyst reports. Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Truist Financial raised their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Friday, January 10th. Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Finally, Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $31.00.

Institutional Trading of Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Champlain Investment Partners LLC raised its position in Phreesia by 4.1% during the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after acquiring an additional 97,847 shares during the last quarter. Franklin Resources Inc. raised its position in Phreesia by 3.0% during the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after acquiring an additional 42,973 shares during the last quarter. State Street Corp raised its position in Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Geode Capital Management LLC raised its position in Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after acquiring an additional 55,934 shares during the last quarter. Finally, TimesSquare Capital Management LLC raised its position in Phreesia by 2.3% during the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after acquiring an additional 19,395 shares during the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.